Description

Glimepirid-TEVA tablets 3 mg. №30

Ingredients:

Each tablet contains 3 mg of Glimepiride.

Dosage:

The recommended dosage is determined by a healthcare provider based on individual needs.

Indications:

Glimepirid-TEVA tablets are indicated for the treatment of type 2 diabetes mellitus.

Contraindications:

Do not use Glimepirid-TEVA tablets in patients with type 1 diabetes or diabetic ketoacidosis.

Directions:

Take Glimepirid-TEVA tablets as directed by your healthcare provider, usually once daily with a meal.

Scientific Evidence:

Glimepiride, the active ingredient in Glimepirid-TEVA tablets, is a sulfonylurea that works by increasing insulin release from the pancreas, thereby lowering blood sugar levels. Studies have shown that Glimepiride is effective in improving glycemic control in patients with type 2 diabetes.

Research published in the Journal of Diabetes Investigation demonstrated that Glimepiride, when used as monotherapy or in combination with other antidiabetic agents, significantly reduced HbA1c levels and improved overall glucose control.

Additional Information:

It is important to monitor blood sugar levels regularly while taking Glimepirid-TEVA tablets to ensure optimal control of diabetes. Additionally, consult your healthcare provider before starting or stopping any medication.

Clinical trials have shown that Glimepiride is well-tolerated and has a low risk of hypoglycemia when used appropriately. However, like all medications, it may cause side effects in some individuals. If you experience any unusual symptoms, seek medical attention promptly.